Anaïs de Vos was 27 when she attended a job interview for the French Ministry of Culture in July 2011. She recalls that the senior civil servant, Christian Nègre, offered her a cup of coffee that tasted “bad.” After a few minutes of walking outside, she experienced a sudden, uncontrollable urge to urinate and told Nègre she needed a bathroom.

Nègre allegedly directed her to a storage cupboard under a bridge on the Seine, encouraging her to relieve herself there. – The incident ended with Anaïs wetting herself, a moment she described as “weak, scared, and terrified.” The cry of privacy and humiliation made her leave the interview with her self‑confidence profoundly shaken.

Anaïs joined a network of almost 250 women who allege that Nègre drugged candidates with a diuretic in an attempt to control them during interviews between 2009 and 2018. The substance increases urine output and has been labelled “chemical submission.” The claim is reinforced by a spreadsheet discovered on Nègre’s computer titled “Experiments P,” which recorded the timing of drug administration, the interval before urination, and the clothing of victims.

In 2019, lawyers for the police notified Anaïs of the evidence that labeled her an alleged victim. The case points to a pattern that has emerged in France: the use of unsuspected drugs to facilitate sexual assault. It has prompted political figures such as MP Sandrine Josso to lobby for a pilot program where victims can submit biological samples for testing without a formal police complaint.

The investigation into Nègre began after a colleague captured a photo of him secretly photographing an interviewee. He was suspended as regional director of cultural affairs and later fired by the Ministry of Culture. He faces charges of drugging, privacy violations, and sexual assault, but his trial has been delayed, giving victims a sense of “secondary victimization.”

Prosecutors report that Nègre’s alleged victims were not initially aware of the drug. Many only realized they were monitored when police reached out to them, or when Anaïs’s story was broadcast. The delay in justice has left victims struggling with ongoing physical and psychological problems.

The debate over drug‐facilitated interview misconduct highlights the need for swift protective measures and comprehensive supporting services for survivors. France’s lawmakers are pressured to establish clearer protocols, expand testing, and ensure that those accused are held accountable quickly and fairly.